Cancer treatment is evolving, with a focus on reducing treatments and improving patient comfort without compromising recovery. Studies are underway to determine if reducing surgery, chemotherapy, or radiation can benefit patients with ovarian, esophageal, and blood cancers. Research has shown that less invasive surgery and reduced chemotherapy in advanced ovarian cancer and Hodgkin lymphoma can lead to improved patient outcomes and fewer complications.